Participate in MDMA Studies
We are currently recruiting for the Phase 3 study of MDMA-assisted therapy for PTSD. Here is a list of all MAPS-sponsored trials on clinicaltrials.gov.
Read our Publications
MAPS PBC publishes research papers detailing the results of our clinical trials.
MAPS PBC in the Media
New PTSD Treatments Emerge as Cases Rise Among Some Groups
Sept. 21, 2020
PTSD and psychoactive drugs: MDMA treatment shows potential, but others lack evidence
Sept. 21, 2020
The case for funding psychedelics to treat mental health
Oct 9, 2020
MDMA-assisted couples therapy investigated in landmark pilot trial
December 08, 2020
Press Releases
First Controlled Trial of Cannabis for the Treatment of PTSD Raises no Safety Concerns, Further Research is Needed to Determine Efficacy
Widespread anecdotal reports of benefit have led to self-treatment of the symptoms of posttraumatic stress disorder (PTSD) with cannabis among Veterans and others; the safety and potential efficacy of such treatments have not previously been studied through randomized...
MAPS Public Benefit Corporation Expands Talent with Three Leadership Hires
MAPS Public Benefit Corporation (MAPS PBC), a wholly-owned subsidiary of the Multidisciplinary Association of Psychedelic Studies (MAPS), has recently expanded their team with three new leaders bringing decades of...
MAPS-Sponsored Pilot Study: MDMA-Assisted Psychotherapy for PTSD in Couples May Reduce PTSD Symptoms, Improve Couples’ Happiness
Cognitive-behavioral conjoint therapy (CBCT) for posttraumatic stress disorder (PTSD), when combined with MDMA, resulted in significant improvements in PTSD symptoms Six couples, in which one partner was diagnosed with PTSD, participated in a seven-week protocol; both...
Numinus and MAPS Public Benefit Corporation Announce Collaboration Agreement to Seek Approval of MDMA-Assisted Psychotherapy for PTSD Single-Arm, Open-Label Trial
Numinus and MAPS Public Benefit Corporation announce collaboration agreement to seek approval of MDMA-assisted psychotherapy for PTSD single-arm, open-label trial First-of-its-kind trial in Canada will pave the way for expanded MDMA-assisted treatment to support...
MAPS PBC is a wholly-owned subsidiary of the Multidisciplinary Association for Psychedelic Studies (MAPS). MAPS is a 501(c)(3) non-profit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana.